| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/04/2009 | EP0881906B2 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 02/04/2009 | EP0821589B1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 02/04/2009 | CN101360999A Intraocular pressure-regulated early genes and uses thereof |
| 02/04/2009 | CN101360998A Na+, k+-atpase expression in cervical dysplasia and cancer |
| 02/04/2009 | CN101360829A Fermentation and culture method, fermented plant extract, composition containing fermented plant extract, method for producing lipopolysaccharide and lipopolysaccharide |
| 02/04/2009 | CN101360752A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 02/04/2009 | CN101360751A Oxygen linked pyrimidine derivatives |
| 02/04/2009 | CN101360750A Method of modulating stress-activated protein kinase system |
| 02/04/2009 | CN101360749A Salts of clopidogrel with polynions and their use for manufacturing pharmaceutical formulations |
| 02/04/2009 | CN101360748A Inhibitors of c-met and uses thereof |
| 02/04/2009 | CN101360746A Pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
| 02/04/2009 | CN101360745A 8-azabicyclo[3.2.1]octane derivatives useful as monoamine reuptake inhibitors |
| 02/04/2009 | CN101360744A Pure and stable tiotropium bromide |
| 02/04/2009 | CN101360743A Polycyclic 1, 2, 3, 4 -tetrahydro- isoquinoline derivatives and compositions comprising them as ppar modulators |
| 02/04/2009 | CN101360742A Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 02/04/2009 | CN101360741A Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators |
| 02/04/2009 | CN101360740A Aminopyrimidines useful as kinase inhibitors |
| 02/04/2009 | CN101360738A Compositions and methods for modulating gated ion channels |
| 02/04/2009 | CN101360737A 2-amino-5-piperidinylimidazolone compounds and use thereof for (insert beta symbol)-secretase modulation |
| 02/04/2009 | CN101360736A L-alanine derivatives |
| 02/04/2009 | CN101360735A Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| 02/04/2009 | CN101360733A Dnt-fumarate and methods of preparation thereof |
| 02/04/2009 | CN101360728A Iap bir domain binding compounds |
| 02/04/2009 | CN101360722A Novel 2-aminopyrimidine derivatives and their use |
| 02/04/2009 | CN101360721A Novel 2-aminopyrimidinone or 2-aminopyridinone derivatives and their use |
| 02/04/2009 | CN101360720A Novel 2-aminopyrimidinone derivatives and their use |
| 02/04/2009 | CN101360718A Novel hydrogen sulfate salt |
| 02/04/2009 | CN101360717A Novel heterocycles |
| 02/04/2009 | CN101360716A Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer s disease, neurodegeneration and dementia |
| 02/04/2009 | CN101360715A Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer's disease, neurodegeneration and dementia |
| 02/04/2009 | CN101360714A Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 02/04/2009 | CN101360712A New pleuromutilin derivative and its use |
| 02/04/2009 | CN101360709A Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (PBR) |
| 02/04/2009 | CN101360705A Amino-alkyl-amide derivatives as CCR3 receptor ligands |
| 02/04/2009 | CN101360698A Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity |
| 02/04/2009 | CN101360506A Methods for wound healing |
| 02/04/2009 | CN101360505A Pharmaceutical compositions comprising polymeric binders with non-hydrolysable covalent bonds and their use in treating celiac disease |
| 02/04/2009 | CN101360504A Quetiapine in a controlled release formulation |
| 02/04/2009 | CN101360503A Liquid formulations |
| 02/04/2009 | CN101360502A Crystalline forms |
| 02/04/2009 | CN101360501A Treatment of substance abuse |
| 02/04/2009 | CN101360500A Use of morpholino compounds for the treatment of halitosis |
| 02/04/2009 | CN101360499A Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases |
| 02/04/2009 | CN101360498A Calcilytic compounds |
| 02/04/2009 | CN101360497A Novel process and formulations |
| 02/04/2009 | CN101360496A Neuroendocrine tumor treatment using mTOR inhibitors |
| 02/04/2009 | CN101360495A Administration of mntor inhibitor to treat patients with cancer |
| 02/04/2009 | CN101360494A Chemical synthesis of a highly potent epothilone |
| 02/04/2009 | CN101360493A Levetiracetam formulations and methods for their manufacture |
| 02/04/2009 | CN101360492A Compositions containing ansamycin |
| 02/04/2009 | CN101360491A Combination of a 5-HT4 agonist with a cholinesterase inhibitor |
| 02/04/2009 | CN101360490A Composition with docosapentaenoic acid |
| 02/04/2009 | CN101360489A Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
| 02/04/2009 | CN101360488A Chemical compounds |
| 02/04/2009 | CN101360487A Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms |
| 02/04/2009 | CN101360486A Nanoparticles for protein drug delivery |
| 02/04/2009 | CN101360485A Hydrophilic vehicle-based dual controlled release matrix system |
| 02/04/2009 | CN101360429A Method for stimulating intestinal barrier integrity after non-natural birth |
| 02/04/2009 | CN101360426A Novel use of a nutraceutical composition in animal feed |
| 02/04/2009 | CN101360422A Oncogenic ras-specific cytotoxic compound and methods of usethereof |
| 02/04/2009 | CN101360421A Nicotinoyl riboside compositions and methods of use |
| 02/04/2009 | CN101360419A Chemical compounds |
| 02/04/2009 | CN101358379A Combination therapy wherein a serotonin reuptake inhibitor is used |
| 02/04/2009 | CN101357952A Polysaccharide MA from Mytilus coruscus with hypolipidemic activity and preparation method thereof |
| 02/04/2009 | CN101357939A Protein conjugate and pharmaceutical compositions thereof |
| 02/04/2009 | CN101357929A Cephalosporin derivative containing sulfhydryl thiadiazole |
| 02/04/2009 | CN101357924A Dipeptidase-IV inhibitor compound |
| 02/04/2009 | CN101357923A Dipeptidase inhibitor compound |
| 02/04/2009 | CN101357922A New DPP-IV inhibitor |
| 02/04/2009 | CN101357921A New dipeptidase-IV inhibitor compound |
| 02/04/2009 | CN101357920A Penem derivative containing sulfhydryl pyrrolidine formamido triazine |
| 02/04/2009 | CN101357919A Penem derivative containing sulfhydryl formamide benzenesulfonyl pyrrolidine |
| 02/04/2009 | CN101357918A Penem derivative containing isothioureido sulfhydryl pyrrolidine |
| 02/04/2009 | CN101357917A Carbapenem compound containing formyl hydrazino |
| 02/04/2009 | CN101357916A Penem compound containing dihydroimidazole formamido |
| 02/04/2009 | CN101357915A Diazabicyclic central nervous system active agents |
| 02/04/2009 | CN101357914A Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 02/04/2009 | CN101357906A Novel triazolols antifungal compound, preparation method and application thereof |
| 02/04/2009 | CN101357901A Chiral 1,4-dihydro-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic carboxylate, preparation method and application thereof |
| 02/04/2009 | CN101357893A Ethylene diamine metalloid protease inhibitor and use thereof |
| 02/04/2009 | CN101357888A Method for preparing ferrous rosmarinci acid and magnesian rosmarinci acid and antibacterial activity application thereof |
| 02/04/2009 | CN101357883A Antrodia camphoratea pimelie kelone compound for treating autoimmune disease and medicine composition |
| 02/04/2009 | CN101357223A Preparation method of anti-stress agent for fishing |
| 02/04/2009 | CN101357209A Chinese herbal medicine composition for promoting wound heal and subcutaneous tissue quickly grow |
| 02/04/2009 | CN101357208A Traditional Chinese medicine composition for treating chronic superficial gastritis |
| 02/04/2009 | CN101357197A Naozhengzhu Duoyuanqu totipotence biological activity traditional Chinese medicine preparation |
| 02/04/2009 | CN101357189A Traditional Chinese medicine composition for treating atrophic gastritis |
| 02/04/2009 | CN101357172A External traditional Chinese medicine for treating hyperosteogeny, urgent lumbar sprain, joint bursitis |
| 02/04/2009 | CN101357169A Medicine for quickly treating snake bite |
| 02/04/2009 | CN101357160A Traditional Chinese medicine formulation for treating insomnia |
| 02/04/2009 | CN101357153A No-scar medicine for treating burn and scald and preparation method thereof |
| 02/04/2009 | CN101357148A Ginseng-pearl formulation and preparation method thereof |
| 02/04/2009 | CN101357141A Water-soluble mixing active pearl calcium and preparation method thereof |
| 02/04/2009 | CN101357140A Vitamin-adding high-peptide pearl active calcium replenishing agent and preparation method thereof |
| 02/04/2009 | CN101357139A Multivitamin selenium-enriched active pearl oral preparation and preparation method thereof |
| 02/04/2009 | CN101357137A Use of a vitreoscilla filiformis lipopolysaccharide fraction as an agent for stimulating the synthesis of anti-microbial skin peptides |
| 02/04/2009 | CN101357136A Composition of traditional Chinese medicine effective constituent for preventing and treating diseased associated with cerebral ischemia injury |
| 02/04/2009 | CN101357135A Anti-cancer medicine composition containing anti-metabolism medicine |
| 02/04/2009 | CN101357134A Potenciador del efecto antitumoral y agente antitumoral |
| 02/04/2009 | CN101357133A Composition for treating hyperlipemia |